2022-05-11 16:26:00
Eevia Health Plc receives a 3,3 MSEK/0,33 MEUR sales order for bilberry extract
Eevia Health Plc, ("Eevia" or "The Company"), has received a sales order from its Australian distributor Ingredients Plus. Ingredients Plus serves leading nutraceutical brands in Oceania and Asia with high-quality ingredients. The end customer is a major natural health company based out of Sydney, Australia selling its products across Asia and Oceania.
The sales value of this order is c. 334 000 EUR, and the product is Feno-Myrtillus bilberry extract standardized with 36% anthocyanins. The order is in line with expectations for repeat sales of this product going forward.
"With the war in Ukraine, which has been a large bilberry exporter, Eevia Health is being sought out as a supplier of organic berry extracts, since we are located next to the berry harvest areas in Finland and Sweden," says Stein Ulve, CEO of Eevia.
The Feno-Myrtillus® product range is extracted from arctic bilberries. The powder is deep blue, almost black due to the high concentration of anthocyanins, a polyphenol with benefits to human health.
This disclosure contains information that EEVIA HEALTH PLC is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on May 11, 2022.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc Gabriella Beni, CFO, Eevia Health Plc
Email: [email protected] [email protected]
Telephone: +358 400 22 5967 +358 407 48 8666
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product; Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, Chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. The factory operates near the raw material harvest areas. A uniquely short value chain enables an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.
Nerladdningsbara filer
Eevia Health Plc receives a 230 KSEK/21 KEUR starting sales order for a new Lingonberry product to a new customer
2022-06-27 12:29
Eevia Health Plc, ("Eevia" or "The Company"), has received a 21 KEUR sales order from its Australian distributor Ingredients Plus for a new product made from Lingonberry, after a new customer has decided to launch a new product with the Lingonberry ingredient as a key component.
Eevia Health Plc has secured a credit line of SEK 8 million for working capital purposes to finance continued growth
2022-06-24 13:16
Eevia Health Plc, ("Eevia" or "The Company"), has entered into an agreement whereby Exelity AB, Sweden will provide a credit line for Eevia of up to SEK 8 million, giving the Company increased working capital flexibility to finance its continued growth.
Communique from the Annual General Meeting in Eevia Health Plc
2022-06-21 13:31
The Annual General Meeting of Shareholders of Eevia Health Plc, corp. reg. no 2825194-4 (the "Company") was held on June 21, 2022 in Seinäjoki, Finland, whereby the shareholders primarily resolved the following matters:
Eevia Health Plc receives a 2,3 MSEK/0,23 MEUR sales order for organic bilberry extract
2022-06-09 09:32
Eevia Health Plc, ("Eevia" or "The Company"), has received a sales order from its Australian distributor Ingredients Plus. Ingredients Plus serves leading nutraceutical brands in Oceania and Asia with high-quality ingredients. The end customer is a major natural health company based out of Sydney, Australia selling its products across Asia and Oceania.
Notice of the Annual General Meeting of Shareholders 2022
2022-06-02 15:39
The shareholders of Eevia Health Abp, company registration number 2825194-4 in Finland, are hereby called for the Annual General Meeting (AGM) to be held on June 21st 2022.
Eevia Health Plc publishes Financial Statements for 2021
2022-05-31 08:20
Eevia Health Plc's (''Eevia'' or ''the Company'') Financial Statements for 2021 together with the Auditors' report have been published today.
Eevia Health Plc Interim Report Q1-2022
2022-05-27 14:42
Eevia Health Plc successfully participates at Vitafoods trade show in Geneva
2022-05-11 18:00
Eevia Health Plc, ("Eevia" or "The Company"), is taking part in the trade show "Vitafoods" in Geneva this week (10-12 May 2022).
Eevia Health Plc receives a 3,3 MSEK/0,33 MEUR sales order for bilberry extract
2022-05-11 16:26
Eevia Health Plc, ("Eevia" or "The Company"), has received a sales order from its Australian distributor Ingredients Plus. Ingredients Plus serves leading nutraceutical brands in Oceania and Asia with high-quality ingredients. The end customer is a major natural health company based out of Sydney, Australia selling its products across Asia and Oceania.
Eevia Health appoints a Shareholders' Nomination Committee
2022-04-14 15:03
Eevia Health Plc, ("Eevia" or "The Company") has appointed a Shareholders' Nomination Committee
Eevia Health Plc
Webbplats:
eeviahealth.com/investors/
Kortnamn: EEVIA
Marknadsplats: Spotlight stock market
Senaste rapporten:
Annual report 2021
Nästa evenemang:
2022-08-29 Delårsrapport Q2 2022
Kurs
Kurs:
Marknadsvärde: